Aridis Pharmaceuticals

Aridis Pharmaceuticals

Biotechnology, 983 University Ave BLDG B, Los Gatos, California, 95032, United States, 11-50 Employees

aridispharma.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 40********

Who is ARIDIS PHARMACEUTICALS

Aridis Pharmaceuticals is a late-stage clinical development company leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections. The...

Read More

map
  • 983 University Ave BLDG B, Los Gatos, California, 95032, United States Headquarters: 983 University Ave BLDG B, Los Gatos, California, 95032, United States
  • 1995 Date Founded: 1995
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ARIDIS PHARMACEUTICALS

Aridis Pharmaceuticals Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Aridis Pharmaceuticals

Answer: Aridis Pharmaceuticals's headquarters are located at 983 University Ave BLDG B, Los Gatos, California, 95032, United States

Answer: Aridis Pharmaceuticals's phone number is 40********

Answer: Aridis Pharmaceuticals's official website is https://aridispharma.com

Answer: Aridis Pharmaceuticals's revenue is $1 Million to $5 Million

Answer: Aridis Pharmaceuticals's SIC: 2834

Answer: Aridis Pharmaceuticals's NAICS: 325412

Answer: Aridis Pharmaceuticals has 11-50 employees

Answer: Aridis Pharmaceuticals is in Biotechnology

Answer: Aridis Pharmaceuticals contact info: Phone number: 40******** Website: https://aridispharma.com

Answer: Aridis Pharmaceuticals is a late-stage clinical development company leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections. The companys pipeline of novel mechanism antibacterial and antivirals, sprung from its proprietary technology platforms, are designed to combat the growing public health threat of antimicrobial resistant bacteria (AMR).

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access